Legal Representation
Attorney
Gregory B. Phillips
USPTO Deadlines
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 15, 2025 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Oct 15, 2025 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Oct 22, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Oct 22, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Oct 22, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 22, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 8, 2024 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 8, 2024 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Oct 8, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 26, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 25, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Apr 25, 2024 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 25, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 25, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 23, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Oct 23, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Oct 23, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 27, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 25, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Apr 25, 2023 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Apr 25, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Oct 26, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 24, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 24, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 24, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 26, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 1, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 1, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 9, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 27, 2022 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED | Loading... |
| Jan 27, 2022 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jan 26, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 26, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 25, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 25, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 2, 2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Nov 2, 2021 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Nov 2, 2021 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jul 27, 2021 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | Loading... |
| Jul 27, 2021 | GPRA | F | PRIORITY ACTION E-MAILED | Loading... |
| Jul 27, 2021 | CPRA | R | PRIORITY ACTION WRITTEN | Loading... |
| Jul 16, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 8, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 12, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products targeting selected biological pathways, namely, for the treatment of autoimmune and neurodegenerative diseases and for use in organ and cellular transplantation
Class 042
Pharmaceutical research and development and medical research and development in the field of autoimmune and neurodegenerative diseases
Additional Information
Design Mark
The mark consists of a blue stylized letter "E" displayed backwards and adjacent to a blue stylized letter "P".
Color Claim
The color blue is claimed as a feature of the mark.
Pseudo Mark
ELEDON PHARMACEUTICALS
Classification
International Classes
005
042